Cargando…

Recent Advances in the Development of Virus-Like Particle-Based Flavivirus Vaccines

Flaviviruses include several medically important viruses, such as Zika virus (ZIKV), Dengue virus (DENV), West Nile virus (WNV) and Japanese encephalitis virus (JEV). They have expanded in geographic distribution and refocused international attention in recent years. Vaccination is one of the most e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Naru, Li, Chaoqun, Jiang, Shibo, Du, Lanying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565697/ https://www.ncbi.nlm.nih.gov/pubmed/32867194 http://dx.doi.org/10.3390/vaccines8030481

Ejemplares similares

Current advancements and potential strategies in the development of MERS-CoV vaccines
por: Zhang, Naru, et al.
Publicado: (2014)

Recent Advancements in Mosquito-Borne Flavivirus Vaccine Development
por: Wu, Bingan, et al.
Publicado: (2023)

Current development of COVID-19 diagnostics, vaccines and therapeutics
por: Zhang, Naru, et al.
Publicado: (2020)

Current Progress in the Development of Zika Virus Vaccines
por: Zhou, Kehui, et al.
Publicado: (2021)

Recent Advances in the Use of Plant Virus-Like Particles as Vaccines
por: Balke, Ina, et al.
Publicado: (2020)

Roles of the hemagglutinin of influenza A virus in viral entry and development of antiviral therapeutics and vaccines
por: Jiang, Shibo, et al.
Publicado: (2010)

Receptor-binding domain-based subunit vaccines against MERS-CoV
por: Zhang, Naru, et al.
Publicado: (2015)

Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain
por: Zhou, Yusen, et al.
Publicado: (2019)

Recent Developments in Vaccines against Flaviviruses and Alphaviruses
por: Kim, Young Chan, et al.
Publicado: (2023)

Receptor-binding domains of spike proteins of emerging or re-emerging viruses as targets for development of antiviral vaccines
por: Jiang, Shibo, et al.
Publicado: (2012)

Recent advance in the development of tuberculosis vaccines in clinical trials and virus-like particle-based vaccine candidates
por: Zhou, Fangbin, et al.
Publicado: (2023)

Advancement in the Development of Therapeutics Against Zika Virus Infection
por: Li, Kangchen, et al.
Publicado: (2022)

Middle East respiratory syndrome: current status and future prospects for vaccine development
por: Du, Lanying, et al.
Publicado: (2015)

Development of SARS vaccines and therapeutics is still needed
por: Jiang, Shibo, et al.
Publicado: (2013)

Corrigendum: Advancement in the development of therapeutics against Zika virus infection
por: Li, Kangchen, et al.
Publicado: (2022)

Learning from the past: development of safe and effective COVID-19 vaccines
por: Su, Shan, et al.
Publicado: (2020)

Virus-like Particle Vaccines and Platforms for Vaccine Development
por: Kheirvari, Milad, et al.
Publicado: (2023)

Respiratory Viruses and Virus-like Particle Vaccine Development: How Far Have We Advanced?
por: Chu, Ki-Back, et al.
Publicado: (2023)

Vaccines for the prevention against the threat of MERS-CoV
por: Du, Lanying, et al.
Publicado: (2016)

Flavivirus NS1 and Its Potential in Vaccine Development
por: Carpio, Kassandra L., et al.
Publicado: (2021)

Memory T Cells in Flavivirus Vaccination
por: Li, Guangyu, et al.
Publicado: (2018)

Recent Progress on the Versatility of Virus-Like Particles
por: Qian, Ciying, et al.
Publicado: (2020)

Chimeric Vaccines Based on Novel Insect-Specific Flaviviruses
por: Harrison, Jessica J., et al.
Publicado: (2021)

Adenovirus-based vaccines against avian-origin H5N1 influenza viruses
por: He, Biao, et al.
Publicado: (2015)

Research advancements in the neurological presentation of flaviviruses
por: Chen, Tingting, et al.
Publicado: (2018)

Yeast-Based Virus-like Particles as an Emerging Platform for Vaccine Development and Delivery
por: Srivastava, Vartika, et al.
Publicado: (2023)

Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus
por: Tang, Jian, et al.
Publicado: (2015)

mRNA Vaccines against Flaviviruses
por: Wollner, Clayton J., et al.
Publicado: (2021)

Virus-Like Particles and Nanoparticles for Vaccine Development against HCMV
por: Perotti, Michela, et al.
Publicado: (2019)

Zika Virus: Recent Advances towards the Development of Vaccines and Therapeutics
por: McArthur, Monica A.
Publicado: (2017)

Physico-chemical requirements and kinetics of membrane fusion of flavivirus-like particles
por: Espósito, Danillo L. A., et al.
Publicado: (2015)

Usutu Virus: An Emerging Flavivirus in Europe
por: Ashraf, Usama, et al.
Publicado: (2015)

Virus-Like Particle Systems for Vaccine Development against Viruses in the Flaviviridae Family
por: Wong, Shu Hui, et al.
Publicado: (2019)

A Perspective on Current Flavivirus Vaccine Development: A Brief Review
por: Dutta, Sudip Kumar, et al.
Publicado: (2023)

Bioinformatics in New Generation Flavivirus Vaccines
por: Koraka, Penelope, et al.
Publicado: (2010)

Recent Advances in Zika Virus Vaccines
por: Garg, Himanshu, et al.
Publicado: (2018)

Mosquito-Borne Flaviviruses and Current Therapeutic Advances
por: Qian, Xijing, et al.
Publicado: (2022)

Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases
por: Yang, Jing-Xing, et al.
Publicado: (2022)

Platforms, advances, and technical challenges in virus-like particles-based vaccines
por: Gupta, Reeshu, et al.
Publicado: (2023)

Escherichia coli-derived virus-like particles in vaccine development
por: Huang, Xiaofen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lo6s10gd6bjdu1vtqg6v73bmcl